Browsing by Author Sze, MF

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 20 of 24  next >
TitleAuthor(s)Issue Date
 
A comprehensive study on the effects of antioxidant supplements in liver cancer development and treatment.
Proceeding/Conference:Health Research Symposium 2021
Zhang, XSze, MFChan, LKHo, DWHTsui, YMChiu, YTLee, EHusain, AHuang, HYTian, LWong, CCLNg, IOL
2021
 
Antioxidant supplements may accelerate the formation and progression of hepatocellular carcinoma in vitro and in vivo
Proceeding/Conference:Cancer Research
Zhang, XLee, ETsui, YMSze, MFChiu, YTChan, LKHo, DWHZhao, LLam, MWLTian, LLee, JMFLee, DWong, CCLNg, IOL
2018
 
Antioxidant supplements may enhance tumor initiation and growth in hepatocellular carcinoma and counteract the therapeutic effects of Sorafenib
Proceeding/Conference:American Association for Cancer Research (AACR) Annual Meeting
Zhang, XLee, ETsui, YMSze, MFChiu, YTChan, LKHo, DWHLee, MFWong, CCLNg, IOL
2020
 
Application of an inducible gene expression system to functionally study hepatitis B virus X protein
Proceeding/Conference:Health Research Symposium
Sze, MFNg, IOL
2007
 
C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma
Journal:Hepatology
Sze, MFChu, KYLee, MFNg, IOL
2013
 
C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway
Journal:Oncotarget
Ching, HHSze, MFLau, YTChiu, YTLee, MFNg, IOLLee, KW
2017
 
Characterization of a novel MAD1 isoform, MAD1β, in hepatocellular carcinoma
Proceeding/Conference:Research Postgraduate Symposium, RPS 2006
Sze, MFChing, YPJin, DNg, IOL
2006
 
Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma
Journal:Oncotarget
Tsui, YMSze, MFTung, KKHo, DWHLee, KWNg, IOL
2017
 
Dysregulation of mitotic spindle checkpoint control in hepatocellular carcinomas
Proceeding/Conference:Research Postgraduate Symposium, RPS 2005
Sze, MFChing, YPJin, DNg, IOL
2005
 
Dysregulation of mitotic spindle checkpoint control in hepatocellular carcinomas
Proceeding/Conference:Cancer Research
Sze, MFChing, YPJin, DNg, IOL
2004
 
Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma
Journal:Hepatology
Tian, LSze, MFMing, SIWang, XZhang, XHo, DWHCheung, TTChan, LKNg, IOL
2021
 
Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma
Journal:Journal of Hepatology
HUSAIN, AChiu, YTSze, MFHo, DWHTsui, YMSuarez, EMSZhang, XChan, LKLee, ELee, MFCheung, TTWong, CCLChung, YSCNg, IOL
2022
 
Exogenous Antioxidants, N-acetylcysteine and Glutathione, Enhance Cancer Initiation and Growth in Hepatocellular Carcinoma
Proceeding/Conference:International Liver Cancer Association (ILCA) Annual Conference 2021
Zhang, XChan, LKSze, MFHo, DWHTsui, YMChiu, YTLee, ETian, LWong, CCLNg, IOL
2021
 
Location-Specific Hematoma Volume Cutoff and Clinical Outcomes in Intracerebral Hemorrhage
Journal:Stroke
Teo, KCSze, MFLeung, WCYLeung, IYHWong, YKChoi, OMYYam, KKLo, RCNCheung, RTFHo, SLTsang, ACOLeung, GKKChan, KHLau, KK
22-May-2023
 
PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis
Journal:Nature Communications
Ko, FCFChan, LKSze, MFYeung, YSTse, EYTLu, PYu, MHNg, IOLYam, JWP
2013
 
Proline-rich acidic protein 1 (PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma.
Journal:Journal of Pathology
Sze, MFChu, KYMak, HYLee, MFNg, IOL
2014
 
RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma
Journal:Oncotarget
Ma, WSze, MFChan, LKLee, MFWei, LWong, CMLee, KWWong, CCLNg, IOL
2016
 
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
Proceeding/Conference:The 11th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2021)
Ho, DWHTsui, YMChan, LKSze, MFZhang, XCHEU, WSChiu, YTLee, MFChan, ACYCheung, ETYYau, DTWChia, NHLo, ILOSham, PCCheung, TTWong, CCLNg, IOL
2021
 
Single-cell RNA sequencing unravels the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
Proceeding/Conference:International Liver Cancer Association (ILCA) Annual Conference 2021
Ho, DWHTsui, YMChan, LKSze, MFZhang, XCheu, JWSChiu, YTLee, MFChan, ACYCheung, ETYYau, DTWChia, NHLo, ILOSham, PCCheung, TTWong, CCLNg, IOL
2021
 
Single-Cell Transcriptome Sequencing Reveals Intra-Tumor Heterogeneity and Rare Stemness-Related Cell Subpopulation in Hepatocellular Carcinoma
Proceeding/Conference:Liver Cancer
Ho, DWHTsui, YMSze, MFChan, LKCheung, TTCheng, LLee, EWu, ARSham, PCTsui, SKLee, TKNg, IOL
2018
Showing results 1 to 20 of 24  next >